Veeva Systems Inc
NYSE:VEEV

Watchlist Manager
Veeva Systems Inc Logo
Veeva Systems Inc
NYSE:VEEV
Watchlist
Price: 216.58 USD 0.95% Market Closed
Market Cap: 35.1B USD
Have any thoughts about
Veeva Systems Inc?
Write Note

Veeva Systems Inc
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Veeva Systems Inc
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Veeva Systems Inc
NYSE:VEEV
Income from Continuing Operations
$615.3m
CAGR 3-Years
13%
CAGR 5-Years
16%
CAGR 10-Years
35%
Teladoc Health Inc
NYSE:TDOC
Income from Continuing Operations
-$981.7m
CAGR 3-Years
-7%
CAGR 5-Years
-56%
CAGR 10-Years
N/A
Inspire Medical Systems Inc
NYSE:INSP
Income from Continuing Operations
$33m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Income from Continuing Operations
$147.6m
CAGR 3-Years
43%
CAGR 5-Years
80%
CAGR 10-Years
N/A
Omnicell Inc
NASDAQ:OMCL
Income from Continuing Operations
-$17.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
W
Waystar Holding Corp
NASDAQ:WAY
Income from Continuing Operations
-$51.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Veeva Systems Inc
Glance View

Market Cap
35B USD
Industry
Health Care

Veeva Systems Inc. is a cloud-based software company that specializes in providing innovative solutions for the life sciences industry. Founded in 2007, Veeva has grown into a leading player, helping pharmaceutical and biotechnology companies manage their critical data and workflow efficiently. With an array of products tailored to various functions such as clinical trials, regulatory compliance, and commercial operations, Veeva’s offerings are designed to streamline processes while ensuring compliance with the stringent regulations that govern the healthcare sector. The company has established a robust reputation and a vast customer base, including many of the world's most prominent drug manufacturers, which highlights its strategic importance in an ever-evolving industry. Investors looking at Veeva Systems should note the company’s impressive growth trajectory, characterized by consistent revenue increases and a strong margin profile. As healthcare increasingly shifts towards digital solutions, Veeva stands at the forefront of this transformation, capturing the growing demand for cloud-based applications. Moreover, Veeva’s commitment to innovation and its customer-centric approach position it well to capitalize on future opportunities within life sciences, particularly as the industry seeks to enhance efficiency and reduce costs. With a strong balance sheet and a business model that emphasizes recurring revenue through subscription services, Veeva Systems presents a compelling investment proposition for those interested in the intersection of technology and healthcare.

VEEV Intrinsic Value
121.68 USD
Overvaluation 44%
Intrinsic Value
Price

See Also

What is Veeva Systems Inc's Income from Continuing Operations?
Income from Continuing Operations
615.3m USD

Based on the financial report for Jul 31, 2024, Veeva Systems Inc's Income from Continuing Operations amounts to 615.3m USD.

What is Veeva Systems Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
35%

Over the last year, the Income from Continuing Operations growth was 14%. The average annual Income from Continuing Operations growth rates for Veeva Systems Inc have been 13% over the past three years , 16% over the past five years , and 35% over the past ten years .

Back to Top